We and others have shown that the encoded transmembrane PTP acts as an oncogene in gliomas [21, 39, 40] and, interestingly, two HLA-presented peptides derived from PTPRZ1’s extracellular part are included in an experimental glioma vaccine that is currently explored in phase II clinical trials [41]. This evidence concerns the gene PTPRZ1 and glioma.